HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aberrant phenotypes in peripheral T cell lymphomas.

Abstract
Seventy six peripheral T cell lymphomas were examined immunohistologically to test their reactivity with a panel of monoclonal antibodies against 11 T cell associated antigens (CD1-8, CD27, UCHL1, and the T cell antigen receptor). Sixty two (82%) lymphomas showed aberrant phenotypes, and four main categories were distinguished as follows: (i) lack of one or several pan-T cell antigens (49, 64% of the cases); (ii) loss of both the CD4 and CD8 antigens (11, 15% of the cases); (iii) coexpression of the CD4 and CD8 antigens (13, 17% of the cases); and (iv) expression of the CD1 antigen (eight, 11% of the cases). No correlation was seen between the occurrence of aberrant phenotypes and the histological subtype. It is concluded that the demonstration of an aberrant phenotype is a valuable supplement to histological assessment in the diagnosis of peripheral T cell lymphomas. It is recommended that the panel of monoclonal antibodies against T cell differentiation antigens should be fairly large, as apparently any antigen may be lost in the process of malignant transformation.
AuthorsN Hastrup, E Ralfkiaer, G Pallesen
JournalJournal of clinical pathology (J Clin Pathol) Vol. 42 Issue 4 Pg. 398-402 (Apr 1989) ISSN: 0021-9746 [Print] England
PMID2469701 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, CD1
  • Antigens, Differentiation
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Neoplasm
  • CD8 Antigens
Topics
  • Antibodies, Monoclonal
  • Antigens, CD1
  • Antigens, Differentiation (analysis)
  • Antigens, Differentiation, T-Lymphocyte (analysis)
  • Antigens, Neoplasm (analysis)
  • Biopsy
  • CD8 Antigens
  • Humans
  • Lymphoma (genetics, immunology, pathology)
  • Phenotype
  • T-Lymphocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: